Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"blood: 175.9"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	22	"basophil: 175.9;eosinophil: 152.0"	"Lineage enriched"	"Detected in many"	92	"granulocytes: 175.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB003795	Uncertain									"CAB003795: AB_562259"	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.6	0.2	0.3	2.9	1.1	0.4	0.3	0.2	0.8	0.3	1.3	0.2	0.2	2.9	0.8	0.2	0.4	0.5	1.3	0.3	0.2	0.2	0.5	1.2	5.8	0.6	0.3	0.2	0.2	0.3	0.0	0.3	7.0	0.7	1.0	1.4	0.9	2.4	0.2	3.2	3.6	5.1	1.6	0.5	2.7	2.2	0.4	0.2	0.6	1.8	2.8	0.6	4.0	0.3	0.0	0.2	175.9	0.0	0.0	1.9	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.7	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.1	0.3	0.1	0.0	0.2	0.0	24.9	0.0	2.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.1	2.7	2.1	0.0	0.0	0.5	0.0	175.9	0.0	152.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.2	1.9	0.3	0.3	1.1	0.2	0.8	0.2	0.2	0.3	0.2	0.7	0.2
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"blood: 494.6"	"Cell line enriched"	"Detected in some"	94	"HEL: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 494.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 494.6"					"Low region specificity"	"Detected in all"			"CAB022102, HPA036051, CAB055526"	Approved									"CAB022102: , CAB055526: , HPA036051: "	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	5.8	1.4	1.6	3.6	0.8	6.0	9.2	0.9	1.3	8.0	3.4	1.1	3.4	3.2	10.6	5.6	12.1	2.0	25.4	4.1	4.3	1.3	3.6	2.4	27.8	0.6	1.0	5.3	1.5	2.6	0.5	1.9	0.5	2.7	9.4	5.4	6.5	5.9	4.7	1.2	17.9	4.1	6.0	2.8	3.5	2.3	1.5	6.8	2.4	2.5	19.7	16.2	3.8	4.9	0.0	75.4	494.6	0.3	0.4	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	494.6	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	75.4	0.0	0.0	0.1	0.4	0.4	0.2	10.4	0.0	3.0	1.6	0.8	0.9	1.3	4.3	1.3	1.0	5.3	2.7	6.8
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"blood: 19.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 2.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	199	"basophil: 19.8"	"Lineage enriched"	"Detected in single"	199	"granulocytes: 19.8"																																					0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC092442.1		ENSG00000284684			4	6064977-6070162	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	16	"blood: 1.5"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.5;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in single"	15	"hypothalamus: 0.7"																																	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0										
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682676	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	16	"blood: 73.8"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	679	"basophil: 73.8"	"Lineage enriched"	"Detected in single"	679	"granulocytes: 73.8"					"Low region specificity"	"Detected in many"			HPA072995	Approved				"Secreted to blood"	7157				"HPA072995: "	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.4	1.2	0.3	1.1	0.3	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	1.1	0.3	0.7	0.8	0.8	0.3	0.3	0.1	0.5	0.3	4.6	1.1	0.3	0.3	0.3	0.3	3.7	1.4	0.3	0.3	0.4	0.0	0.3	0.4	0.3	0.3	1.6	1.0	0.3	0.3	0.7	0.2	1.0	0.3	1.3	0.8	0.3	0.3	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3
HRH4	"AXOR35, GPCR105, GPRv53, H4R, HH4R"	ENSG00000134489	"Histamine receptor H4"	Q9H3N8	18	24460629-24479957	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"blood: 48.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.9;HL-60: 4.9;HMC-1: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	96	"basophil: 48.5;eosinophil: 16.7"	"Lineage enriched"	"Detected in single"	142	"granulocytes: 48.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035009	Uncertain									"HPA035009: AB_10671507"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.83e-6)"	"unprognostic (1.31e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.65e-7)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-4)"	"unprognostic (7.70e-2)"	1.7	0.6	0.4	1.5	0.4	2.8	0.6	0.3	0.3	0.4	0.6	0.3	0.3	2.1	1.4	1.9	1.3	0.3	0.8	0.5	0.4	0.4	0.4	1.7	1.9	0.7	0.4	0.3	0.8	0.4	0.0	2.5	0.3	0.8	1.0	0.4	1.0	1.1	0.3	0.8	2.3	1.9	2.8	2.6	1.4	0.9	1.4	0.3	0.3	0.5	0.3	5.1	1.9	0.6	0.0	0.0	48.5	0.0	0.0	0.3	0.1	0.4	0.3	0.2	0.9	0.1	0.0	0.5	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.5	0.2	0.8	0.2	0.3	0.2	0.2	0.2	2.9	0.9	0.6	0.2	4.9	2.9	0.2	1.0	0.1	0.0	0.3	0.2	0.5	0.1	0.4	0.4	0.8	0.3	0.3	0.3	0.3	0.3	0.5	0.6	0.4	0.2	0.2	0.1	0.2	0.3	1.1	0.3	1.2	0.2	0.8	0.1	0.5	0.2	0.2	0.9	0.8	0.5	48.5	0.0	16.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.3
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924816-104937790	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"blood: 229.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 34.0;RPMI-8226: 24.4;THP-1: 61.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 229.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 229.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051512	Uncertain						2000000			"HPA051512: "	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.7	1.6	8.9	6.7	8.8	15.0	1.9	5.7	10.0	1.5	1.3	23.1	0.1	5.6	1.5	0.5	1.1	2.8	3.5	0.8	8.7	8.4	1.2	0.9	2.6	14.4	14.5	3.4	0.9	1.6	1.0	2.8	1.2	9.0	2.1	0.8	1.5	4.6	2.3	0.5	0.9	5.5	0.9	19.0	11.6	3.5	0.8	9.2	2.7	1.0	0.0	11.2	3.9	0.9	14.7	229.9	43.4	17.7	1.7	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	8.6	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	2.8	43.4	0.0	11.9	0.1	14.7	0.0	0.0	35.1	12.3	0.1	0.0	0.6	1.7	17.7	229.9	0.0	4.4	8.9	8.8	5.7	9.6	8.7	8.4	14.5	3.4	9.0	9.2
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"blood: 298.5"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 298.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 298.5"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"					"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favourable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favourable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	6.4	0.7	0.8	8.0	1.1	26.4	3.2	0.7	0.7	1.6	3.0	0.5	1.3	0.8	3.9	1.5	4.0	1.0	3.1	4.8	0.7	2.4	2.1	5.7	21.7	16.7	1.1	0.0	1.4	0.7	0.0	1.0	7.5	0.8	2.6	0.9	4.0	2.7	2.3	3.5	0.6	2.9	1.8	1.5	33.0	3.5	0.9	0.4	6.1	4.4	5.3	16.8	6.0	1.5	0.2	298.5	2.0	0.2	19.9	60.5	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	2.9	0.3	0.1	0.2	60.5	0.1	0.7	0.2	4.6	28.4	0.2	0.1	1.4	28.7	2.0	19.9	0.2	298.5	0.1	53.6	0.8	1.1	0.7	0.7	0.7	2.4	1.1	0.0	0.8	0.4
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"blood: 15.9"	"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	160	"basophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"																																					0.0	0.0		0.1		0.6	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.3	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.6			0.0		0.0	0.1		0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC134669.1		ENSG00000265118			17	31305213-31318831	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	8	"blood: 57.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 5.4;HMC-1: 5.2;Karpas-707: 4.8;MOLT-4: 9.3;RPMI-8226: 7.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 57.6"	"Low lineage specificity"	"Detected in all"											HPA045033	Uncertain									"HPA045033: "	"unprognostic (5.33e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"		"unprognostic (5.88e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.45e-5)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"		2.4	0.3	1.4	6.6	2.1	3.0	0.5	0.5	4.5	0.3	1.1	0.5	0.2	1.2	0.5	1.1	0.8	0.7	2.0	0.4	2.6	1.5	0.6	0.7	4.9	4.0	6.8	1.8	0.6	0.3	0.1	0.4	2.0	2.1	0.7	1.2	0.5	2.2	0.6	0.6	0.4	2.6	1.1	4.4	4.5	2.4	0.8	4.3	2.2	0.7	0.2	5.9	1.7	0.5	9.3	14.7	57.6	24.1	4.7	12.3	20.3	0.1	0.0	0.0	0.0	0.0	5.4	0.1	0.4	1.0	0.6	1.2	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	3.4	1.7	5.2	1.2	0.0	0.0	2.2	0.0	0.0	4.8	1.8	0.0	9.3	0.8	0.0	0.0	2.9	0.6	7.5	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.1	1.8	2.1	0.9	0.2	1.1	1.2	4.6	0.0	3.5	0.3	1.6	1.1	1.7	24.1	2.0	8.6	11.0	7.9	9.3	10.0	8.9	14.7	5.6	10.1	9.1	57.6	4.7	10.9	4.8	12.3	20.3	1.4	2.1	0.5	4.5	2.6	1.5	6.8	1.8	2.1	4.3
CLEC4C	"BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL"	ENSG00000198178	"C-type lectin domain family 4 member C"	Q8WTT0	12	7729415-7751605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"blood: 80.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	16	"plasmacytoid DC: 80.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 80.0"									HPA029432	Approved									"HPA029432: AB_10601259"	"unprognostic (3.55e-3)"	"unprognostic (3.01e-2)"		"unprognostic (1.03e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.37e-5)"		"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	0.3	0.2	0.2	1.6	0.2	1.8	2.0	0.2	0.6	0.2	0.2	0.1	0.1	0.0	0.2	0.1	0.3	0.5	1.2	0.3	0.2	0.2	0.5	0.3	1.5	7.0	0.2	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.4	0.3	2.0	0.2	0.3	0.3	0.1	0.2	4.6	0.3	9.9	0.1	6.7	0.3	0.1	7.1	1.9	0.3	0.5	80.0	4.9	0.1	0.5	0.0	0.5	0.2	0.0	0.3	0.3	0.5	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.2	6.5	0.1	0.3	0.7	0.2	0.0	0.6	1.3	0.4	0.3	0.0	0.0	0.1	0.2	1.0	0.0	0.1	0.1	0.8	1.4	0.2	0.1	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.1	0.0	0.9	0.1	0.4	0.4	0.2	0.1	0.1	0.6	0.2	1.4	0.1	0.3	0.3	0.9	0.1	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	2.6	0.5	0.0	80.0	0.0	0.5	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.1	0.1	0.1
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"														"Secreted to blood"						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9
MAP1LC3B2	ATG8G	ENSG00000258102	"Microtubule associated protein 1 light chain 3 beta 2"	A6NCE7	12	116548105-116576448	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"blood: 33.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA042824: , HPA052474: , HPA052484: , HPA053767: "	"unprognostic (1.50e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-3)"	"unprognostic (6.66e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.42e-1)"	0.4	3.5	0.4	0.4	0.4	2.0	0.4	0.4	1.8	0.4	0.7	0.4	0.4	2.2	1.0	0.4	0.5	0.0	0.4	0.4	0.4		0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.0	0.4	0.4	2.6	0.4	0.2	0.4	0.8	0.4	3.9	1.1	0.8	0.6	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.7	0.4	7.0	8.0	33.1	10.1	7.2	11.4	8.5	2.6	0.0	0.7	2.9	0.4	1.4	1.6	3.0	0.6	0.2	0.4	3.7	2.6	0.1	3.7	0.7	1.6	1.1	0.8	1.2	0.7	0.0	0.0	0.6	3.1	2.3	1.9	1.8	0.4	1.0	2.3	1.9	0.5	1.6	4.7	0.7	0.9	1.4	2.9	1.6	0.7	2.0	0.4	0.6	0.4	1.4	0.9	4.3	1.2	1.1	11.1	1.5	0.2	0.9	4.0	1.1	3.5	2.6	3.8	2.9	4.6	4.7	1.2	2.4	22.7	9.3	25.1	6.6	8.9	6.2	7.0	7.4	6.3	7.7	6.1	5.1	5.6	33.1	7.2	10.1	8.0	11.4	8.5										
AC107959.5		ENSG00000284956			8	23084403-23115536	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"blood: 69.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.3;HDLM-2: 16.3"									"Cell type enriched"	"Detected in some"	9	"neutrophil: 69.8"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 69.8"																																					0.3	2.0	0.0	1.5	0.0	3.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	2.7	0.0	0.0		3.5	0.0	0.4	0.0	0.7	0.0	0.4	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	9.7	0.5	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	69.8	0.4	0.0	0.0	0.1	2.6	3.7	0.7	13.3	0.0	1.7	2.8	0.0	0.5	0.2	2.1	0.4	1.1	2.7	4.0	0.9	0.1	0.4	0.5	1.9	16.3	1.6	0.0	2.0	7.5	1.6	0.5	5.7	1.7	2.1	0.7	0.7	2.5	0.7	0.0	0.6	0.0	0.0	0.7	3.5	0.5	0.1	0.9	0.3	0.8	0.1	0.1	0.1	0.2	1.9	4.8	1.8	0.3	1.3	4.7	6.7	6.7	0.8	6.3	4.7	0.2	5.2	1.2	4.0	0.6	0.4	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.8	0.0	0.3	0.0	0.0	0.1										
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607886	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 178.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.0;Karpas-707: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 178.9"	"Group enriched"	"Detected in many"	133	"NK-cells: 53.0;T-cells: 178.9"					"Low region specificity"	"Detected in all"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favourable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favourable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favourable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (1.17e-2)"	3.8	0.8	0.8	22.8	0.8	18.6	2.1	0.5	0.6	2.9	9.1	0.0	1.3	5.0	1.8	3.7	2.6	1.8	7.3	1.3	0.7	0.8	3.8	4.9	11.8	23.7	1.1	0.2	2.0	1.0	0.0	0.9	2.1	0.8	1.8	3.9	0.9	4.8	1.4	0.9	0.8	20.4	0.6	1.8	25.2	4.4	1.3	0.2	6.2	1.9	2.9	17.7	5.5	2.0	0.1	0.3	0.8	0.2	53.0	178.9	18.5	0.0	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.0	0.2	1.9	0.0	0.0	0.2	0.0	3.0	0.0	0.4	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.8	0.8	0.6	0.5	0.0	1.1	0.2	0.9	0.0	0.5	0.4	0.6	0.6	0.7	0.1	0.3	0.2	0.0	1.6	0.0	0.4	0.7	0.6	0.4	1.5	0.0	1.8	0.9	0.5	0.1	0.0	43.1	0.1	178.9	0.1	25.6	28.1	0.1	0.1	1.5	8.7	0.8	53.0	0.2	0.3	5.7	18.5	0.8	0.8	0.5	0.6	0.7	0.8	1.1	0.2	0.8	0.2
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206052723-206102459	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 117.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 185.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 42.8;ovarian cancer: 41.1"					"Cell type enriched"	"Detected in some"	51	"basophil: 117.7"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 117.7"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"				"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.3	0.0	0.0	3.9	0.0	0.0	1.8	0.0	0.0	13.1	3.1	0.0	12.1	0.9	6.2	8.2	3.4	1.6	16.2	0.4	0.0		6.8	1.8	5.2	4.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	9.4	3.3	2.9	0.0	16.9	1.5	0.2	4.0	7.0	0.0	0.4	2.4	1.1	0.0	0.6	0.0	1.7	2.5	4.3	10.0	0.3	2.2	117.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.1	0.0	8.4	185.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	37.2	0.0	0.0	0.0	0.0	0.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	117.7	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2										
CLC	"Gal-10, LGALS10, MGC149659"	ENSG00000105205	"Charcot-Leyden crystal galectin"	Q05315	19	39731250-39738028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 489.7"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 408.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	256	"basophil: 489.7;eosinophil: 448.3"	"Lineage enriched"	"Detected in single"	1987	"granulocytes: 489.7"									HPA041751	Enhanced						240000			"HPA041751: AB_10793973"		"unprognostic (4.53e-2)"	"unprognostic (3.04e-2)"		"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.34e-2)"	"unprognostic (6.60e-2)"		"unprognostic (2.21e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.24e-1)"	1.0	0.3	1.1	5.0	0.7	80.4	0.3	0.3	1.3	0.7	1.6	1.9	0.3	4.8	0.3	1.3	0.3	0.2	2.9	0.6	0.3	2.3	0.3	1.2	6.3	0.3	0.4	1.2	0.3	0.7	0.0	0.6	1.5	0.7	0.3	1.2	0.3	2.6	0.3	1.5	0.2	8.1	4.4	0.4	13.8	2.8	0.6	0.3	6.4	0.4	0.3	0.3	9.2	0.3	0.1	0.1	489.7	0.2	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	408.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	489.7	0.1	448.3	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	1.8	0.0	0.2	0.1	0.0	1.6	1.1	0.7	0.3	1.3	0.3	2.3	0.4	1.2	0.7	0.3
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698854	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 444.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;NB-4: 3.5;THP-1: 1.2;U-2197: 2.0;U-87 MG: 2.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 226.1;NK-cell: 444.6"	"Group enriched"	"Detected in many"	55	"NK-cells: 444.6;T-cells: 226.1"									"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	2923333				"CAB025186: , HPA058021: "	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favourable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favourable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favourable (8.07e-4)"	7.1	1.0	2.1	3.5	2.3	72.0	3.3	1.2	2.0	1.7	2.4	5.8	0.0	1.2	31.5	2.2	4.4	2.0	2.1	4.0	2.3	3.2	1.8	5.7	20.8	10.7	3.8	0.8	1.0	0.6	0.1	1.4	45.2	3.6	3.2	2.1	4.9	2.6	1.9	5.7	0.8	12.4	1.4	4.2	34.3	1.5	0.7	1.8	2.0	2.4	3.9	5.9	2.3	1.6	0.8	1.5	6.1	0.8	444.6	226.1	175.3	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.6	0.3	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.3	0.8	0.0	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.0	0.0	0.4	0.1	0.0	2.5	0.6	0.0	4.0	0.7	0.4	226.1	0.6	61.2	0.8	26.0	96.4	0.6	0.5	7.4	89.8	6.1	444.6	0.8	1.5	1.0	175.3	2.1	2.3	1.2	2.0	2.3	3.2	3.8	0.8	3.6	1.8
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 134.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 134.9"					"Low region specificity"	"Detected in all"			HPA029200	Enhanced				"Secreted to blood"					"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favourable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.6	3.1	1.1	5.0	1.2	16.5	3.6	0.5	1.0	1.9	3.1	0.4	0.2	0.9	1.0	2.7	2.6	1.8	8.1	4.8	1.0	1.1	1.7	3.6	16.4	11.5	2.6	1.3	3.0	1.1	0.0	3.7	1.6	1.2	4.5	1.1	5.1	5.4	4.2	4.5	0.8	2.2	2.0	3.1	22.6	2.5	2.5	0.7	0.2	2.5	3.4	6.4	5.1	1.9	0.4	3.2	1.8	0.3	17.6	134.9	82.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.4	0.9	1.8	0.2	0.1	134.9	0.2	2.4	0.4	41.8	109.7	0.2	0.2	13.9	102.7	1.5	17.6	0.3	3.2	0.3	82.9	1.1	1.2	0.5	1.0	1.0	1.1	2.6	1.3	1.2	0.7
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	9	"HMC-1: 5.1;SK-MEL-30: 10.4;U-2 OS: 3.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2
SMIM27	"C9orf133, TOPORS-AS1"	ENSG00000235453	"Small integral membrane protein 27"		9	32551144-32568621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in many"	6	"blood: 102.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 102.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 102.4"																				"prognostic favourable (4.18e-5)"	"prognostic favourable (6.11e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.74e-3)"	"unprognostic (8.58e-2)"	"prognostic favourable (8.39e-4)"	"prognostic favourable (7.33e-5)"	"unprognostic (1.30e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (7.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-3)"	4.0	6.9	5.0	4.3	12.2	7.9	5.6	4.8	11.0	4.0	4.0	2.4	4.4	4.8	2.2	7.8	2.3	4.0	2.1	8.6	5.1		6.2	3.9	5.6	8.8	5.7	5.8	3.7	11.5	3.7	5.5	2.1	8.9	4.4	1.6	4.0	5.9	4.6	13.8	2.1	3.9	4.5	11.4	6.6	5.1	16.2	6.1	4.5	2.8	4.7	4.1	2.6	0.0	18.4	8.4	102.4	7.6	13.3	22.0	9.9	7.1	4.0	7.4	6.7	3.2	10.0	4.1	3.8	5.5	2.9	5.9	1.0	1.9	5.5	5.5	5.4	2.9	5.0	3.3	4.2	10.7	11.3	27.1	12.3	9.0	7.5	6.6	4.7	7.3	5.3	2.8	6.7	6.6	3.8	14.0	5.2	5.4	11.7	27.4	9.2	7.8	6.1	3.5	9.7	6.7	3.7	5.6	6.9	8.9	3.5	4.5	2.8	5.8	3.8	2.0	5.5	2.7	3.6	15.6	11.9	19.4	12.4	4.1	1.8	13.6	7.3	47.4	12.7	7.2	16.9	17.6	18.3	14.7	6.1	18.4	22.0	19.0	102.4	13.3	7.6	8.4	18.3	9.9										
TNFRSF10C	"CD263, DcR1, LIT, TRAILR3, TRID"	ENSG00000173535	"TNF receptor superfamily member 10c"	O14798	8	23102590-23117437	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 173.4"	"Group enriched"	"Detected in some"	5	"BEWO: 37.1;HUVEC TERT2: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 173.4"	"Lineage enriched"	"Detected in many"	113	"granulocytes: 173.4"									CAB025635	Enhanced									"CAB025635: "	"unprognostic (2.63e-1)"	"unprognostic (4.49e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.74e-3)"	"unprognostic (4.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.54e-2)"	5.5	1.5	1.9	14.0	3.6	12.6	2.0	1.4	3.9	2.9	1.5	0.7	0.1	1.2	1.5	1.2	1.4	3.7	13.5	5.6	1.9	1.1	2.8	3.2	13.7	28.4	9.2	0.0	2.4	2.1	2.5	4.5	12.8	3.1	2.7	1.8	1.7	1.7	0.8	2.3	0.8	2.2	1.9	4.4	26.4	1.8	1.4	2.3	0.8	4.4	0.5	0.9	5.2	1.9	0.0	0.3	173.4	1.5	0.0	0.0	0.4	0.4	1.4	0.5	2.4	0.0	0.3	37.1	1.5	0.0	0.1	0.1	0.0	1.4	0.1	0.7	1.4	0.2	0.1	0.1	0.1	2.5	0.5	0.1	0.3	1.1	3.6	0.2	1.0	4.1	0.3	0.7	0.3	30.9	0.0	0.0	0.2	1.0	0.0	0.9	1.6	0.0	0.1	0.1	0.0	5.9	0.1	0.0	0.0	0.1	0.2	0.7	5.1	0.2	6.5	0.6	1.2	1.4	0.1	1.5	0.8	0.0	2.2	0.3	0.9	2.7	1.5	25.4	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	173.4	0.0	1.1	0.0	0.0	0.4	1.9	3.6	1.4	3.9	1.9	1.1	9.2	0.0	3.1	2.3
AC097637.1		ENSG00000173366			3	52221081-52231190	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"blood: 31.7"	"Group enriched"	"Detected in some"	5	"Daudi: 11.4;RPMI-8226: 21.3;U-698: 10.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.7"																								"unprognostic (4.08e-2)"					"unprognostic (9.63e-2)"								0.3	0.0	0.4	2.9	0.7	0.3	0.1	1.1	0.5	0.3	0.4			0.1	0.2	0.0	0.1	0.1	0.6	0.3	0.4	0.4	0.2	0.1	0.1	6.5	0.3		0.8	0.0	0.0	0.0	0.2		0.2	0.0		0.5	0.1	1.4	0.3	4.0	0.0	0.3	6.2	0.5	0.0			0.1		5.3	1.0	0.2	7.0	31.7	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.2	0.7	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.8	0.4	10.5	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.2	7.0	0.5	0.5	0.1	3.7	0.0	0.2	0.1	0.0	0.0	31.7	1.1	0.6										
AC106774.10		ENSG00000284552			5	17486231-17486829	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"blood: 12.2"	"Cell line enriched"	"Detected in single"	10	"U-937: 8.3"									"Cell type enriched"	"Detected in single"	122	"neutrophil: 12.2"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.2"																																					0.0	0.0		1.5		0.7	0.0		0.0	0.0	0.0			0.0	0.0	2.6	0.0	0.2	0.8	0.0			0.0	0.0	0.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		1.2	0.0	0.0			0.0		0.0	0.0		0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0										
AL034430.1		ENSG00000285508			20	10413520-10431922	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	5	"blood: 31.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 39.5"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																																			4.4	1.7		5.0		6.3	0.0		0.6	0.0	2.5			3.2	0.0	0.0	1.2	0.0	0.0	6.2			0.0	2.8	0.0	1.0			0.0	3.7	0.0		0.4		1.3	0.0		1.6	0.0	0.0	0.0	2.3	0.0		0.0	4.3	2.9			0.0		0.0	0.0		8.2	31.4	19.1	16.3	4.3	7.4	5.0	17.6	9.3	5.8	7.6	0.0	1.0	8.1	12.5	3.6	5.2	5.7	6.4	19.3	5.0	8.0	2.8	13.1	0.0	11.5	10.0	1.4	3.0	9.2	7.7	39.5	2.9	17.8	6.0	1.5	0.0	2.9	6.3	7.8	10.7	13.4	6.9	7.2	4.2	20.0	11.0	8.7	8.1	16.8	11.2	4.3	12.0	2.7	4.4	11.5	19.9	25.8	9.5	8.5	9.2	11.9	14.3	10.2	16.1	6.8	10.3	12.4	5.8	10.2	11.4	19.1	13.7	15.7	4.7	16.3	5.5	8.2	5.6	7.4	13.4	6.7	5.3	6.4	11.8	4.3	13.7	31.4	6.5	5.0										
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133399995-133475222	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 12.7"	"Group enriched"	"Detected in some"	7	"Daudi: 5.5;U-698: 6.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"T-reg: 12.7"	"Lineage enriched"	"Detected in single"	48	"T-cells: 12.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"				"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	14.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.2	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913860	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 138.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.9;HEL: 21.2;HMC-1: 45.5;THP-1: 16.4;U-937: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 138.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004379, HPA066571"	Enhanced						1200000			"CAB004379: AB_627449, HPA066571: "	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favourable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	13.6	3.3	0.6	14.2	0.6	8.4	3.5	0.5	0.6	2.4	4.4	0.4	2.1	3.5	2.0	5.9	3.8	2.8	4.8	3.8	0.6	0.7	2.7	4.6	14.0	12.3	1.5	0.2	2.4	2.3	0.0	1.5	5.3	1.4	3.9	1.6	2.6	2.9	0.6	1.4	1.8	5.9	3.4	2.2	28.6	3.2	1.9	0.7	17.9	1.8	2.7	13.5	4.4	9.8	1.4	38.9	138.5	55.9	27.1	52.8	60.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	21.2	0.0	0.0	0.0	0.1	45.5	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.3	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	15.9	0.0	44.9	45.1	138.5	39.0	55.9	18.0	1.4	27.4	29.5	38.9	0.6	15.4	19.1	3.4	27.1	49.3	0.7	52.8	60.8	0.6	0.6	0.5	0.6	0.6	0.7	1.5	0.2	1.4	0.7
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 117.8"	"Cell line enhanced"	"Detected in some"		"HEL: 26.8;HL-60: 15.5;NB-4: 16.1;THP-1: 12.7;U-937: 44.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 117.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 117.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011070	Uncertain									"HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.4	0.8	1.4	15.5	2.7	8.5	1.0	0.6	1.2	1.8	1.4	1.6	0.4	1.8	1.3	2.2	3.3	1.2	3.1	1.1	1.5	1.7	1.6	1.0	7.2	19.4	4.5	0.9	0.7	1.2	0.0	1.5	0.8	4.4	2.6	2.0	1.4	2.3	0.4	0.5	0.9	8.2	2.4	5.9	25.8	1.7	0.8	3.2	5.2	1.1	0.5	23.5	5.1	1.2	12.0	25.4	117.8	8.2	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	15.5	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.6	0.0	12.3	8.2	117.8	0.0	5.7	0.0	12.0	0.0	0.0	9.4	11.9	0.0	0.0	10.1	0.1	6.6	25.4	0.0	3.4	1.4	2.7	0.6	1.2	1.5	1.7	4.5	0.9	4.4	3.2
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193740-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 202.6"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0"	"Region enriched"	"Detected in single"	9	"cerebellum: 7.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 113.6"	HPA047919	Approved						1400000			"HPA047919: "	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favourable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favourable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	6.7	2.1	0.9	23.1	1.1	6.6	2.1	5.3	0.8	4.1	8.4	0.7	1.3	6.1	3.8	9.6	4.0	3.1	8.9	3.1	0.9	0.9	3.4	4.3	34.4	43.2	3.7	0.5	2.1	1.8	0.0	2.7	4.2	2.3	3.4	8.3	6.7	6.7	1.1	1.0	2.2	14.0	4.7	1.8	43.4	3.9	1.9	0.6	14.3	2.6	5.9	25.0	9.8	3.0	0.3	60.5	202.6	59.0	1.4	25.2	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	5.8	59.0	202.6	3.9	36.6	25.2	0.3	7.0	7.4	60.5	0.1	8.3	6.7	126.6	1.4	17.1	46.6	11.1	40.1	0.9	1.1	5.3	0.8	0.9	0.9	3.7	0.5	2.3	0.6
LIM2	"MP17, MP19"	ENSG00000105370	"Lens intrinsic membrane protein 2"	P55344	19	51379909-51387960	"Disease related genes, Predicted membrane proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"blood: 12.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;Hep G2: 1.0"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 18.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"gdT-cell: 12.9"	"Lineage enriched"	"Detected in many"	8	"T-cells: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (5.25e-2)"							"unprognostic (1.09e-3)"		"unprognostic (1.21e-1)"			0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.5	12.9	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.2	1.6	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MTRNR2L12		ENSG00000269028	"MT-RNR2-like 12"	P0DMP1	3	96617188-96618236	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"blood: 603.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 487.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 603.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 603.3"														"Secreted to blood"						"unprognostic (3.79e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.81e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-2)"	18.0	29.1	32.5	5.2	31.0	4.5	7.5	8.8	19.2	5.1	20.2	6.4	5.7	8.1	5.1	75.3	10.9	3.8	40.2	114.2	26.3	19.8	32.9	29.8	5.4	7.8	26.2	7.5	4.9	9.7	4.3	6.6	5.0	10.4	6.9	16.5	6.8	10.8	9.3	101.3	10.6	9.3	6.9	15.3	5.3	13.3	9.7	8.7	72.1	5.1	11.0	5.3	6.0	8.5	69.1	53.1	603.3	81.8	37.9	45.5	57.6	97.6	120.2	90.1	323.3	140.0	75.5	82.8	127.4	26.1	24.5	31.8	66.0	157.9	215.4	103.8	48.0	270.1	6.3	53.8	33.6	63.0	116.3	228.1	487.9	278.0	53.3	45.2	126.3	136.6	64.5	25.8	70.9	27.3	161.6	74.3	83.3	51.1	39.0	142.9	26.2	36.3	62.5	86.6	66.4	147.3	72.7	41.1	80.1	82.9	84.4	109.3	86.7	132.1	120.8	101.7	84.5	113.6	36.0	39.5	24.7	107.0	63.0	285.2	27.4	183.7	81.8	153.2	28.1	44.0	37.0	65.7	35.7	29.9	31.2	69.1	45.5	40.8	603.3	37.9	42.3	53.1	31.4	57.6	32.5	31.0	8.8	19.0	26.3	19.8	26.2	7.5	10.4	8.7
OR11G2		ENSG00000196832	"Olfactory receptor family 11 subfamily G member 2"	Q8NGC1	14	20190894-20201075	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	5	"blood: 5.9"	"Cell line enriched"	"Detected in single"	14	"HEL: 7.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	6	"neutrophil: 5.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.9"																																					0.4	0.2	0.1	0.4	0.1	1.0	0.1	0.1	0.2	0.3	0.1			0.4	0.3	0.6	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1		0.2	0.4	0.0	0.1	0.2		0.2	0.0		0.5	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.2	1.2			0.4		0.0	0.2	0.1	0.3	0.2	5.9	0.3	0.4	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	7.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.8	0.3	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	5.9	0.4	0.2	0.2	0.0	0.0										
OR2A4	OR2A10	ENSG00000180658	"Olfactory receptor family 2 subfamily A member 4"	O95047	6	131699644-131701401	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HMC-1: 1.1;MCF7: 1.7"	"Cancer enriched"	"Detected in single"	17	"renal cancer: 0.8"					"Group enriched"	"Detected in some"	48	"basophil: 10.6;NK-cell: 3.8"	"Group enriched"	"Detected in many"	48	"granulocytes: 10.6;NK-cells: 3.8"									HPA058272	Uncertain									"HPA058272: "													"unprognostic (1.22e-5)"	"unprognostic (3.60e-2)"				0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2			1.4	2.1	0.0	0.0	0.4	0.4	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.1		1.0	0.0		1.0	0.3	0.5	0.0	0.6	0.0	0.0	0.0	0.4	1.1			0.0		0.0	0.9	0.2	0.0	0.0	10.6	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.5	0.5	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.9	0.0	0.3	1.2	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.9	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0										
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 120.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	6.2	6.5	9.1	9.5	9.8	18.7	6.1	6.3	9.8	8.3	6.2	9.6	9.8	6.2	7.4	5.0	15.1	5.7	5.0	6.4	7.3		6.4	6.5	5.5	11.2	7.0	7.1	7.6	5.1	6.9	5.5	7.9	13.5	5.7	5.0	5.7	6.2	6.3	24.6	7.2	6.0	6.8	13.2	6.5	5.8	8.5	9.5	6.8	6.3	4.8	11.7	7.1	3.5	101.9	120.1	118.0	85.5	85.3	89.3	115.9	51.2	42.0	38.4	30.5	13.8	13.6	47.2	31.4	21.3	45.2	33.3	55.4	39.0	47.1	49.7	21.6	35.3	40.8	34.3	37.2	41.7	38.9	36.3	31.8	40.9	19.6	60.5	31.9	14.9	25.9	40.4	43.4	33.5	54.5	44.7	34.7	141.6	60.8	48.0	65.9	73.3	54.0	33.5	46.8	28.9	49.5	39.4	48.3	46.8	24.1	42.6	45.1	73.7	34.5	36.5	46.6	35.8	85.8	50.5	79.6	69.1	32.7	36.5	31.4	89.7	77.6	118.0	86.5	85.5	82.1	101.9	82.5	87.8	76.5	90.1	77.7	86.3	89.3	85.3	79.9	120.1	89.3	115.9										
TLR9	CD289	ENSG00000239732	"Toll like receptor 9"	Q9NR96	3	52221080-52226163	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 33.8"	"Group enriched"	"Detected in some"	12	"Daudi: 24.1;RPMI-8226: 15.4;U-698: 9.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 33.8"																				"unprognostic (6.03e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.69e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.91e-3)"	0.5	0.2	0.0	2.8	0.5	2.5	0.4	4.9	0.4	0.8	1.2			0.7	0.9	0.0	0.2	1.0	0.9	0.3	0.2	0.3	0.3	0.1	0.6	6.5	0.1		2.5	0.0	0.0	0.3	0.1		0.9	0.1		1.4	0.4	1.8	0.1	2.2	0.1	0.4	3.9	0.5	0.3			0.7		3.9	1.2	1.2	3.3	33.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.9	0.7	9.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1										
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4, X-linked"	P62328	X	12975108-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 1074.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB033806	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			400000000	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	122.3	97.5	79.8	105.4	76.4	169.0	87.1	33.2	74.8	92.3	93.3	62.0	59.7	38.5	83.7	67.2	62.7	53.0	92.5	54.9	90.8	67.8	69.6	50.8	134.4	205.2	111.4	84.0	61.9	51.0	4.4	23.4	53.4	74.3	46.6	86.6	31.2	42.3	100.4	28.9	39.6	71.5	75.1	195.6	205.7	98.9	26.4	63.8	96.8	34.4	48.6	154.5	112.2	62.1	296.5	495.3	775.0	554.0	272.7	521.9	1074.5	141.5	118.6	233.1	367.2	285.8	313.3	0.5	75.1	196.5	58.3	100.5	24.4	119.2	33.9	72.6	227.8	62.4	34.5	50.3	78.5	198.2	1.9	42.2	70.3	0.3	66.6	164.9	350.9	145.8	72.2	69.0	60.4	350.3	5.3	0.5	206.3	50.4	196.0	357.9	83.8	81.8	151.1	82.5	138.5	347.1	41.5	24.8	10.5	108.8	5.1	13.8	136.7	167.5	281.7	85.2	42.2	482.6	74.5	110.6	80.3	65.8	130.3	68.4	61.3	544.9	512.5	775.0	364.8	524.7	309.6	296.5	407.3	391.0	495.3	275.6	345.8	349.0	576.0	272.7	554.0	204.1	521.9	1074.5	79.8	76.4	33.2	74.8	90.8	67.8	111.4	84.0	74.3	63.8
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 35.2;WM-115: 9.0"	"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA044988: , HPA077883: "									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959462-27968096	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in all"	10	"eosinophil: 47.1;neutrophil: 24.3"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA049984: , HPA053529: "	"prognostic favourable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	2.6	2.3	2.8	4.2	3.8	10.3	1.8	8.3	1.8	2.3	2.5			4.1	3.3	2.9	2.4	3.2	2.9	3.2	2.8	1.9	3.3	8.6	3.1	3.0	3.0		3.6	8.7	3.5	2.4	7.8		3.5	2.4		5.6	3.7	2.9	2.0	3.1	3.5	4.9	5.6	4.7	1.6			3.5		2.4	2.8	2.4	1.3	2.6	47.1	2.5	2.8	3.0	1.9	4.5	2.4	2.9	2.9	3.3	6.1	7.5	6.8	7.4	8.6	8.9	6.5	3.6	0.0	5.6	7.5	2.5	5.5	3.2	3.1	7.4	9.8	6.0	2.0	4.4	5.3	0.0	0.0	6.5	5.4	9.4	2.6	8.5	0.0	1.8	4.9	2.2	3.3	2.2	13.7	5.6	5.3	0.0	3.2	5.6	2.4	2.1	0.0	2.0	2.7	0.1	2.0	4.6	3.6	6.9	0.2	12.9	2.2	7.2	6.9	0.7	17.1	0.0	0.3	3.5	2.5	47.1	3.0	2.4	2.9	1.3	3.0	2.6	2.6	1.3	2.6	2.6	24.3	2.8	1.7	1.2	2.9	1.9										
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in some"	11	"neutrophil: 20.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.9"									"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047730: , HPA048668: "	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	0.5	0.8		0.1		0.0	2.8		1.4	1.6	0.6			0.3	1.5	0.8	1.4	1.8	0.1	1.8			1.5	0.5	0.9	0.5			3.5	1.1	2.4		0.1		1.8	0.7		1.6	1.4	1.9	4.5	0.0	0.9		1.1	0.6	1.2			2.1		0.9	0.9		1.3	0.4	20.9	0.5	1.8	1.4	0.1	2.7	4.7	4.6	8.7	4.7	5.7	3.5	2.2	4.0	3.0	3.4	0.4	2.1	6.4	2.4	2.1	7.5	3.7	4.3	3.3	0.2	2.3	1.0	3.9	1.0	5.2	3.9	2.3	4.5	9.7	2.9	4.3	5.9	1.2	1.3	3.9	1.6	3.2	2.0	3.9	8.1	0.3	7.4	2.3	3.3	7.2	6.7	4.0	3.4	1.9	3.4	2.7	10.2	1.3	3.9	5.1	3.5	2.6	0.8	3.7	1.5	1.8	1.4	4.1	0.5	0.5	1.5	0.6	0.4	0.1	0.6	0.9	0.8	0.2	1.3	1.4	0.7	20.9	1.8	0.4	0.4	0.5	0.1										
AP000311.1		ENSG00000249209			21	33584687-33931607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	4	"blood: 10.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 10.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	7	"gdT-cell: 5.4;MAIT T-cell: 7.8;memory CD4 T-cell: 7.9;memory CD8 T-cell: 8.1;naive CD4 T-cell: 7.4;naive CD8 T-cell: 6.9;T-reg: 10.8"	"Lineage enriched"	"Detected in many"	9	"T-cells: 10.8"									HPA039558	Uncertain									"HPA039558: "												"unprognostic (4.72e-1)"						0.4	0.4	0.5	1.4	0.6	0.0	0.4	0.8	0.6	0.6	0.5			0.9	0.6	1.8	0.5	0.6	0.3	1.2	0.4	0.4	0.4	0.9	1.0	2.5	0.4		0.7	0.4	0.0	0.3	2.3		0.9	1.1		1.6	0.0	1.2	0.9	0.9	0.0	0.4	0.4	0.9	1.6			0.3		0.0	0.5	0.3	1.1	0.7	1.2	0.4	0.3	10.8	1.2	4.0	0.4	0.1	0.1	0.2	0.0	1.4	0.7	0.0	0.2	0.1	4.4	2.2	0.0	3.5	0.2	1.9	1.0	0.2	0.0	2.7	0.2	1.1	0.2	0.1	0.4	1.8	1.3	0.5	0.0	0.2	0.2	0.0	2.3	5.1	0.0	0.9	2.5	1.0	3.4	2.4	3.5	0.8	1.4	0.0	1.3	3.7	0.4	3.8	2.4	0.3	2.3	2.4	0.0	0.2	10.7	0.3	0.2	2.9	1.7	0.6	2.9	0.8	0.0	1.2	0.4	0.3	5.4	0.3	7.8	1.0	7.9	8.1	0.3	1.1	7.4	6.9	0.6	0.3	0.4	0.7	10.8	1.2										
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969436	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 82.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavourable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	10.6	6.3	0.5	9.7	0.5	6.1	9.4	0.0	0.0	4.7	3.5			8.9	3.5	5.9	14.1	5.8	7.3	4.9	0.5	0.5	6.7	16.5	14.0	10.5	1.0		7.5	16.8	0.0	3.0	10.7		5.8	4.0		11.2	1.9	1.6	10.4	8.8	4.3	2.0	19.0	8.2	0.2			4.2		11.3	8.2	8.0	20.5	29.3	82.8	43.2	29.6	35.7	46.8	6.3	2.1	0.0	2.8	13.7	31.2	5.3	11.0	21.5	17.7	24.8	5.3	29.0	3.3	23.7	14.2	10.6	0.0	19.0	16.9	3.7	0.1	8.6	1.6	13.8	33.6	8.6	4.2	28.3	28.5	21.1	29.5	30.7	0.2	0.0	13.5	0.6	5.0	10.2	0.0	6.3	3.8	4.1	2.9	14.8	10.1	0.1	0.0	10.1	7.2	10.0	2.9	12.6	15.9	18.7	6.5	16.4	7.7	0.0	0.0	0.0	9.5	19.7	13.0	14.9	39.1	7.0	31.5	43.2	34.6	20.5	24.2	30.1	29.3	20.0	14.8	22.0	82.8	29.6	33.5	4.9	35.7	46.8										
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 169.0"	"Cell line enriched"	"Detected in some"	4	"NB-4: 71.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 157.7;memory CD8 T-cell: 169.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 169.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"	21766000	8200000				"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favourable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favourable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	3.6	2.4	0.0	28.8	0.1	17.1	2.6	0.0	0.2	6.0	14.7	1.0	0.6	7.1	5.0	7.2	5.2	1.7	20.5	7.5	0.0		2.7	4.7	29.8	33.5	2.8	0.0	5.9	2.3	0.0	0.1	4.8	1.7	7.8	4.0	8.0	5.5	6.4	2.8	0.0	38.7	2.3	2.2	38.8	6.9	1.9	0.0	12.2	1.6	5.5	27.9	11.5	0.0	1.2	1.1	9.9	0.6	40.8	169.0	106.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.4	2.8	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.1	11.3	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	16.7	0.0	0.0	0.0	0.1	0.0	2.1	0.7	0.1	0.0	15.3	0.1	9.9	0.6	0.7	157.7	0.4	103.8	1.2	36.7	169.0	1.1	0.7	8.8	99.3	4.6	40.8	0.5	0.9	0.5	106.5										
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162845-218166995	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 144.6"	"Cell line enriched"	"Detected in single"	26	"HMC-1: 11.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	16	"neutrophil: 144.6"	"Lineage enriched"	"Detected in many"	59	"granulocytes: 144.6"	"Not detected"	"Not detected"							HPA031991	Uncertain									"HPA031991: "	"unprognostic (2.80e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.85e-2)"	11.5	0.4	0.8	21.1	0.7	7.3	0.6	0.9	2.6	0.6	0.6	0.2	0.0	0.0	0.5	0.1	1.3	2.8	3.6	3.8	0.9	0.6	0.7	2.9	20.3	33.4	5.9	0.0	1.7	1.2	0.0	0.8	2.1	2.3	0.9	0.1	1.4	0.6	0.0	1.0	0.5	0.6	1.4	3.4	33.7	1.0	1.4	0.7	0.1	0.9	0.6	0.4	4.5	4.1	0.0	0.0	144.6	0.2	0.1	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.2	2.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.9	144.6	0.1	0.2	0.0	0.0	0.7	0.8	0.7	0.9	2.6	0.9	0.6	5.9	0.0	2.3	0.7
H2BFS		ENSG00000274559	"H2B histone family member S"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"blood: 16.0"	"Cell line enhanced"	"Detected in many"		"K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.4	0.3		0.5		1.0	0.0		0.0	1.0	0.9			1.4	1.3	2.9	3.3	2.8	2.8	0.0			0.0	2.2	0.3	2.3			0.2	1.2	0.0		0.8		3.7	0.9		1.9	0.0	0.0	0.0	1.8	0.7		0.6	1.1	0.9			1.6		1.0	1.2		7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.0	3.2	0.6	0.9	2.2	0.8	2.3	2.5	1.3	3.2	1.9	4.5	1.0	0.5	8.6	0.8	2.4	0.2	0.7	0.9	2.1	3.5	0.5	4.9	0.2	0.3	0.9	4.4	2.4	0.4	0.6	0.0	0.3	23.2	2.7	0.8	6.0	1.0	2.2	0.3	2.6	0.8	0.5	8.5	0.6	0.7	3.4	2.4	10.2	3.1	2.0	10.9	1.4	0.9	1.7	22.9	1.1	0.6	7.4	23.3	4.9	1.1	11.6	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2										
HIST1H4I	"H4/m, H4FM"	ENSG00000276180	"Histone cluster 1 H4 family member i"	P62805	6	27138588-27139881	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 14.5"	"Cell line enhanced"	"Detected in many"		"K-562: 29.3;SiHa: 17.6;U-2 OS: 30.2;U-266/84: 30.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042201	Approved						30000000			"HPA042201: "	"unprognostic (2.49e-2)"	"prognostic favourable (9.70e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (6.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.02e-2)"	0.1	2.5		2.4		1.7	0.0		0.1	0.0	0.8			2.7	1.1	0.0	1.7	0.0	1.3	0.5			0.0	1.9	0.8	2.6			0.8	2.7	0.0		1.5		2.0	0.0		1.6	0.0	0.0	0.2	2.9	0.0		2.3	3.2	1.8			2.6		0.0	1.9		6.0	5.5	14.5	4.6	2.4	3.4	3.1	1.6	3.4	1.9	1.2	1.3	0.1	2.1	3.3	0.1	0.1	0.1	3.2	2.4	0.5	9.4	0.0	2.6	0.3	0.1	0.0	2.2	5.0	1.1	5.5	0.1	0.2	0.9	6.1	0.4	0.1	0.0	0.1	0.1	29.3	9.0	0.0	5.0	1.4	2.2	0.7	2.1	1.3	1.1	8.2	0.1	0.9	6.3	2.3	17.6	8.1	1.9	15.5	0.7	1.1	2.3	30.2	2.8	0.3	9.1	30.4	5.7	1.3	6.6	2.3	9.2	2.6	14.1	1.5	2.0	1.3	4.6	1.3	1.4	2.5	6.0	1.6	1.7	14.5	2.4	4.6	5.5	3.4	3.1										
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 83.1"	"Group enriched"	"Detected in many"	5	"HEL: 23.0;HUVEC TERT2: 8.1;NTERA-2: 15.8;U-937: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 71.3;MAIT T-cell: 83.1"	"Lineage enriched"	"Detected in many"	28	"T-cells: 83.1"	"Low region specificity"	"Detected in some"							"HPA051403, HPA076494"	Approved		Enhanced	Vesicles				Vesicles		"HPA051403: , HPA076494: "	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	15.4	3.9	4.4	7.3	5.8	5.6	5.7	12.3	5.0	3.2	3.5	7.1	0.8	1.7	5.6	4.2	2.2	2.6	7.7	5.1	4.4	5.8	3.2	6.4	5.5	17.3	8.3	3.4	2.7	1.9	1.5	5.6	1.5	5.5	4.8	4.7	5.6	3.5	1.8	3.1	2.2	5.0	3.9	5.5	19.0	3.6	2.2	6.8	6.8	2.9	2.3	11.1	8.3	2.6	0.5	1.3	2.4	0.6	2.9	83.1	14.0	0.1	2.2	1.2	1.7	2.0	0.4	1.1	0.3	0.3	0.2	0.7	0.7	0.7	3.1	0.1	0.3	0.2	2.8	0.3	0.3	2.2	1.4	23.0	0.3	1.2	0.5	0.7	1.2	1.4	0.3	0.3	0.0	8.1	1.0	0.3	0.1	0.5	0.5	1.6	15.8	1.5	0.9	0.7	0.0	0.3	0.3	0.3	3.1	0.7	0.4	0.9	0.2	1.0	0.5	0.5	0.7	0.4	1.0	1.0	2.7	1.7	1.4	14.5	0.2	2.4	0.3	0.2	71.3	0.4	83.1	0.5	15.8	43.4	1.3	0.5	4.3	29.9	0.9	2.9	0.6	0.5	1.2	14.0	4.4	5.8	12.3	5.0	4.4	5.8	8.3	3.4	5.5	6.8
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098466	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 72.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.9;NB-4: 2.6;THP-1: 4.1;U-937: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	720	"basophil: 72.0"	"Lineage enriched"	"Detected in single"	720	"granulocytes: 72.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059967	Enhanced									"HPA059967: "	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	4.9	0.5	0.4	5.1	0.4	0.2	2.1	0.4	0.4	11.9	4.6	0.1	4.5	4.7	14.3	11.2	5.9	1.1	14.6	2.1	0.4	0.4	1.5	0.9	12.9	0.5	0.4	0.1	1.1	1.2	0.2	0.6	0.6	0.1	17.5	5.6	4.5	3.2	5.4	1.5	4.3	7.4	15.9	0.4	0.6	4.5	2.7	0.2	1.2	0.6	6.7	3.4	5.1	4.1	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	6.9	0.4	0.2	0.3	0.8	0.4	0.1	0.1	0.0	0.1	0.1	0.9	0.3	0.0	0.1	0.0	2.6	0.1	0.1	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.1	0.2	0.0	0.3	4.1	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.2	1.8	0.2	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.2
MTRNR2L1		ENSG00000256618	"MT-RNR2-like 1"	P0CJ68	17	22523111-22524663	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	4	"blood: 249.5"	"Cell line enhanced"	"Detected in all"		"HeLa: 184.9;Hep G2: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 249.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 249.5"														"Secreted to blood"						"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.82e-3)"	"prognostic favourable (8.99e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.21e-3)"	9.4	16.2	7.9	3.7	10.0	2.3	3.0	4.0	8.4	2.5	8.9	3.3	4.8	4.5	2.6	6.8	4.8	2.6	3.3	34.3	8.1	6.1	17.8	12.8	4.2	5.6	8.9	3.0	4.1	15.0	1.5	3.4	2.5	4.6	3.5	7.7	3.3	5.9	5.0	55.5	5.3	5.2	7.5	5.9	3.3	5.6	4.4	4.0	1.8	2.7	6.8	1.8	3.3	2.6	29.4	21.6	249.5	34.3	15.0	18.3	28.7	20.2	47.2	18.2	61.2	28.9	11.9	23.1	19.1	4.5	4.4	5.1	28.9	32.8	27.5	20.9	9.8	53.9	1.3	6.9	5.5	16.1	33.8	25.2	184.9	127.1	9.4	5.9	30.3	26.7	14.8	4.9	12.0	4.7	20.4	16.9	13.2	16.4	9.1	40.4	5.2	10.6	15.0	11.5	14.3	25.1	28.9	9.7	17.2	9.2	17.5	28.1	16.4	42.1	9.1	24.3	20.6	29.0	11.8	15.7	5.0	13.0	13.9	37.2	5.3	74.4	34.3	62.1	10.9	16.7	13.5	28.7	13.9	11.8	12.1	29.4	18.3	15.9	249.5	15.0	16.1	21.6	12.1	28.7	7.9	10.0	4.0	6.8	8.1	6.1	8.9	3.0	4.6	4.0
OR6K6		ENSG00000180433	"Olfactory receptor family 6 subfamily K member 6"	Q8NGW6	1	158754720-158755891	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"blood: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	57	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	57	"granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"blood: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in single"														"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0		0.1		0.7	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.1	0.0	0.5			0.0		0.0	0.0		0.0	3.5	0.0	0.8	0.0	1.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	0.1	0.0	0.0	0.2	1.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4										
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400099	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 138.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.5;HMC-1: 18.4;NB-4: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 138.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 138.4;monocytes: 87.3"									HPA056132	Approved				"Secreted to blood"					"HPA056132: "	"unprognostic (5.53e-2)"	"prognostic favourable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	18.6	5.4	7.2	32.3	7.2	19.4	8.2	15.6	6.2	6.1	4.5	10.6	2.3	3.8	4.8	10.0	2.6	7.5	8.4	6.5	7.7	4.4	8.5	8.0	31.9	30.1	11.0	2.6	5.7	5.1	4.3	9.2	13.2	11.9	6.6	4.9	7.1	3.1	4.1	2.5	2.6	3.9	8.6	18.4	29.5	3.1	6.4	10.7	3.3	5.3	1.1	3.3	9.8	5.4	0.1	24.0	138.4	87.3	0.5	0.2	22.9	0.2	0.2	0.4	0.5	20.5	1.4	0.1	0.1	1.0	0.1	0.3	0.0	0.3	0.4	1.2	0.2	0.6	0.1	0.1	0.0	0.9	0.7	0.4	0.8	0.1	0.2	0.8	18.4	1.4	0.3	0.1	0.4	0.2	0.2	1.2	0.1	0.6	1.4	13.8	0.4	0.2	0.4	0.0	0.3	0.8	0.4	0.5	0.2	0.0	5.1	0.4	0.1	4.2	0.4	0.9	0.9	0.5	0.2	1.8	1.3	0.4	0.2	1.6	0.3	21.3	48.4	1.4	0.2	70.2	0.1	0.1	0.0	0.0	24.0	0.0	0.0	0.1	138.4	0.5	87.3	0.4	0.1	22.9	7.2	7.2	15.6	6.2	7.7	4.4	11.0	2.6	11.9	10.7
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 98.3"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 14.3;HMC-1: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 98.3;monocytes: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	5.6	2.3	2.4	16.2	1.9	20.3	2.4	0.6	2.0	6.9	3.4	1.6	3.5	1.8	2.8	1.4	16.8	2.8	7.5	3.5	2.1	2.3	6.4	1.8	9.2	6.1	4.1	1.0	1.5	2.7	0.9	0.7	3.5	1.8	2.6	3.4	0.6	3.4	2.6	1.1	2.8	5.0	3.8	5.1	15.4	2.3	2.2	1.1	2.3	1.4	22.2	21.7	5.9	3.6	1.5	13.2	98.3	28.2	0.0	0.1	10.1	7.5	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	2.1	0.5	0.0	0.0	5.2	0.2	14.3	0.3	0.1	0.2	2.8	0.0	0.3	0.0	0.7	52.4	0.0	2.3	0.1	0.1	0.0	0.2	0.2	0.0	0.5	0.0	7.1	0.2	0.1	0.1	0.0	0.0	3.5	0.8	0.1	0.0	0.0	7.1	0.0	0.1	2.0	0.0	0.1	0.3	0.0	0.0	0.5	0.4	2.1	0.0	0.9	0.2	5.9	28.2	98.3	0.0	8.9	0.1	1.5	0.0	0.0	13.2	0.7	0.0	0.0	85.7	0.0	3.5	0.1	0.1	10.1	2.4	1.9	0.6	2.0	2.1	2.3	4.1	1.0	1.8	1.1
SH2D1B	EAT2	ENSG00000198574	"SH2 domain containing 1B"	O14796	1	162395266-162412138	"Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 67.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.9;EFO-21: 5.5;Karpas-707: 8.9;PC-3: 1.7;TIME: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"NK-cell: 67.4;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	34	"monocytes: 27.0;NK-cells: 67.4"					"Low region specificity"	"Detected in all"			HPA054791	Uncertain									"HPA054791: "	"unprognostic (7.82e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.89e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.15e-3)"	1.2	0.2	0.4	2.2	0.3	5.3	0.5	0.2	1.1	2.7	3.7	0.1	0.0	1.2	3.0	0.7	3.2	0.3	0.7	1.0	0.5	0.3	0.6	3.9	9.1	6.8	0.4	0.0	0.6	0.2	0.0	0.4	3.7	0.1	1.4	0.6	2.6	1.6	0.9	15.0	0.3	2.6	0.1	1.0	14.8	0.3	0.6	0.0	1.3	0.3	0.4	2.6	0.4	1.7	0.0	1.3	0.6	27.0	67.4	1.3	10.7	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.9	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	8.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.3	5.9	0.0	0.0	0.0	0.3	1.3	0.0	0.1	0.2	0.6	67.4	27.0	0.1	0.0	10.7	0.4	0.3	0.2	1.1	0.5	0.3	0.4	0.0	0.1	0.0
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 63.0"	"Cell line enriched"	"Detected in some"	45	"HMC-1: 57.4"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	42	"eosinophil: 63.0"	"Lineage enriched"	"Detected in single"	623	"granulocytes: 63.0"									HPA012556	Uncertain		Uncertain	Cytosol				Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.6	6.7	5.8	2.4	8.4	0.7	2.3	0.7	7.0	1.4	2.9	7.4	0.0	2.9	1.0	1.1	1.1	1.1	2.7	0.3	8.6	4.8	0.4	1.6	4.1	9.6	8.3	3.6	0.3	0.7	0.7	1.2	0.1	7.5	1.0	2.8	0.1	1.1	0.9	0.3	0.8	4.5	1.5	14.8	9.2	2.1	0.5	6.2	0.6	0.7	0.0	4.1	2.0	0.7	0.0	0.0	63.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.5	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.8	8.4	0.7	5.6	8.6	4.8	8.3	3.6	7.5	6.2
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1563521-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 137.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 24.7;NB-4: 32.8;THP-1: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 137.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 137.6;monocytes: 43.6"									HPA047463	Uncertain		Uncertain	Vesicles			33000000	Vesicles		"HPA047463: "	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	23.7	1.8	2.3	18.7	5.4	31.9	1.8	2.7	3.2	1.1	1.4	1.9	0.1	1.0	1.0	0.5	0.9	2.5	7.6	7.2	2.3	1.6	1.5	7.5	19.4	19.5	6.6	0.7	1.9	0.9	0.1	1.5	3.8	3.7	1.2	1.2	1.7	1.8	0.6	0.9	0.9	2.6	2.1	7.2	28.7	1.2	1.2	3.9	2.5	0.9	0.4	2.9	4.1	1.9	0.2	15.2	137.6	43.6	0.7	1.0	19.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	24.7	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	32.8	0.1	1.5	0.0	0.0	0.0	4.9	0.1	0.0	0.1	0.1	0.0	0.2	0.0	25.4	0.7	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.5	6.0	0.1	0.5	43.6	72.5	0.6	36.3	0.9	0.2	0.6	0.5	15.2	0.2	0.8	0.5	137.6	0.7	29.5	14.5	1.0	19.2	2.3	5.4	2.7	3.2	2.3	1.6	6.6	0.7	3.7	3.9
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: "	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.4	41.2	13.4	20.7	28.7	17.7	21.6	32.6	23.3	20.4	27.4	27.0	29.5	11.8	48.8	22.0	25.5	15.5	18.7	25.4	30.2	19.5	15.1	23.6	28.4	28.0	17.1	18.6	27.0	16.0	26.2	22.3	21.6	19.8	20.9	21.0	56.4	15.9	9.0	15.1	21.3	8.8	23.5	24.3	25.2	23.9	9.6	21.9	18.6	15.8	21.6	32.8	14.7	30.4	27.4	26.2	21.7	26.9	32.4	37.2	16.4	30.2	10.5	27.6	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2
